Companies: 10,795·Total market cap: $144.5T
Nasus Pharma Ltd.

Nasus Pharma Ltd.

NSRXAMEXHealthcare● Active
$3.00
+$0.09(+3.09%)
Market Cap$25837857
P/E Ratio
52W High$9.99
52W Low$1.98
Overview

Nasus Pharma Ltd. (NSRX) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

nsrx · market cap & enterprise value · FMP · as of Jun 9, 2026

Core market cap & key metrics

As of Jun 9, 2026, Nasus Pharma Ltd. (NSRX) has a market cap — also referred to as its net worth or valuation — of $25,837,857, making it one of the top most valuable companies globally. Market Cap = $3.00 × shares outstanding.

Market Cap (Net Worth)$25,837,857nsrx market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0nsrx highest market cap ever
Stock Price$3.00AMEX · Jun 9, 2026
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Nasus Pharma Ltd. (NSRX) has a market cap — also referred to as its net worth or valuation — of $25,837,857 as of Jun 9, 2026, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Nasus Pharma Ltd. reached its all-time high market cap of $0 on —. Comparing the Nasus Pharma Ltd. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Nasus Pharma Ltd. net worth vs peers and ask how Nasus Pharma Ltd. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

NSRX market cap · 6 questions

Nasus Pharma Ltd.'s net worth — measured as market capitalization — is $25,837,857 as of Jun 9, 2026. It ranks #0 globally. Market Cap = $$3.00 (price) × shares outstanding.

NSRX net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.